A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma

A20, known as a potent inhibitor of NF-κB signaling, has been characterized in numerous clinical as well as preclinical studies. Recently, especially in various malignant diseases, the prognostic and therapeutic relevance of A20 was investigated. In oral squamous cell carcinoma (OSCC) however, the c...

Full description

Bibliographic Details
Main Authors: Steffen Spoerl, Ramona Erber, Michael Gerken, Juergen Taxis, Nils Ludwig, Felix Nieberle, Niklas Biermann, Carol Immanuel Geppert, Tobias Ettl, Arndt Hartmann, Philipp Beckhove, Torsten E. Reichert, Gerrit Spanier, Silvia Spoerl
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/3/675